Cellagenics – Amsterdam Academic Ventures

Our portfolio

Cellagenics

Developing STEP® technology, Cellagenics scales up therapeutic antibody production in mammalian cell lines. Their collaboration with Batavia Biosciences aims to enhance biopharmaceutical manufacturing.

Industry: Therapeutics

Want to get in contact about Cellagenics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

RNA-based therapies for rare genetic heart diseases.

Combining quantum computing and classical simulations for material science.

Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.

Advancing molecular diagnostics for precision oncology and infectious diseases.

RNA-based therapies for rare genetic heart diseases.

Combining quantum computing and classical simulations for material science.

Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.

Advancing molecular diagnostics for precision oncology and infectious diseases.

Our portfolio

Want to get in contact about Cellagenics?

Ross Gordon

Our portfolio

Holdings of our founding institutes

Contact